I remember there was a few presentation on intracellular delivery & the same lines of current partners, collaborators etc hence why I was surprised they presented Phenomica when the IC seemed to be the hot place and we were all eagerly awaiting Roche's outcome with moving to license around that space.
Arrowhead presented their DPC technology I believe which incorporates the endosomal escape for siRNA delivery. Not sure if their homing peptides or PDC's where presented but a very interesting space & worth checking out. They had a stellar year in 2013 with 3 drugs now in clinic.
Maybe Phylogica can replicate if the right cards are dealt at this years presentation and more importantly positive Janssen outcome to lead into it would shine a good light
PYC Price at posting:
2.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)